Hirsutism: Difference between revisions
Line 10: | Line 10: | ||
==[[Hirsutism historical perspective|Historical Perspective]]== | ==[[Hirsutism historical perspective|Historical Perspective]]== | ||
Excessive hair often stems from what is considered the “ideal hair pattern” within the culture and society. | |||
In the United States, “ideal” is considered as no terminal hair except for the scalp, eyebrows, eyelashes, and pubis . The terms hirsutism and hypertrichiosis are sometimes used interchangeably. However, hypertrichiosis is defined as excessive hair growth, terminal or vellus, in non-androgen-dependent areas of the body. Hypertrichiosis can be congenital or acquired. | |||
==[[Hirsutism classification|Classification]]== | ==[[Hirsutism classification|Classification]]== |
Revision as of 14:14, 20 September 2017
Hirsutism Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Hirsutism On the Web |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Synonyms and keywords:
Overview
Historical Perspective
Excessive hair often stems from what is considered the “ideal hair pattern” within the culture and society.
In the United States, “ideal” is considered as no terminal hair except for the scalp, eyebrows, eyelashes, and pubis . The terms hirsutism and hypertrichiosis are sometimes used interchangeably. However, hypertrichiosis is defined as excessive hair growth, terminal or vellus, in non-androgen-dependent areas of the body. Hypertrichiosis can be congenital or acquired.
Classification
Pathophysiology
Causes
Differentiating Hirsutism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies